Primel reveals positive results for Active Hand Coating to combat hospital-acquired infections
Primel, a pioneer in the realm of infection prevention solutions, has announced remarkable results from a recent study, confirming the superior sporicidal activity of its ... Read More
Bristol Myers Squibb announces success of KRAZATI in Phase 3 KRYSTAL-12 study
Bristol Myers Squibb (NYSE: BMY) has reached a pivotal milestone in the treatment of non-small cell lung cancer (NSCLC) with its announcement regarding the KRYSTAL-12 ... Read More
MPOWERHealth acquires Assure Neuromonitoring operations to enhance intraoperative care
MPOWERHealth, a leading innovator in the field of intraoperative neuromonitoring (IONM), has made a significant move to expand its services through the strategic acquisition of ... Read More
AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development
In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a pioneer in the development of ... Read More
Lunit announces strategic partnerships to advance AI in cancer diagnostics across Europe
Lunit (KRX:328130.KQ), a frontrunner in AI-powered solutions for cancer diagnostics and therapeutics, is marking a significant milestone in its expansion across Europe through two pivotal ... Read More
Kroger to offload specialty pharmacy business to CarelonRx in strategic shift in healthcare services
The Kroger Co. (NYSE: KR) has announced a definitive agreement for the sale of its specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health, ... Read More
Microsoft and NVIDIA forge ahead with AI and cloud computing in healthcare
Microsoft Corp. is expanding its longstanding partnership with NVIDIA, setting a new benchmark in the integration of generative AI, cloud, and accelerated computing within the ... Read More
Bristol Myers Squibb and 2seventy bio’s Abecma gets positive FDA committee vote for multiple myeloma
In a significant development in the healthcare industry, Bristol Myers Squibb (NYSE: BMY) and 2seventy bio, Inc. (Nasdaq: TSVT) have announced a favorable vote by ... Read More
Zydus Lifesciences gains FDA aproval for Chlorpromazine Hydrochloride Injection
In a notable development for the pharmaceutical industry, Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has received final approval from the United States ... Read More
Asep Medical adopts innovative AI approach to address antibiotic resistance
In a significant announcement at the US Biophysical Society in Philadelphia, Asep Medical Holdings Inc. (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) has shared a breakthrough ... Read More